DK1645558T3 - Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer - Google Patents

Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer

Info

Publication number: DK1645558T3
Authority: DK; Denmark
Prior art keywords: serotonin; piperazinylpyrazines; receptor modulators; ht2c receptor; relates
Prior art date: 2002-06-19

Application number

DK05023471T

Other languages

English (en)

Inventor

Magnus Cernerud

Helena Lundstroem

Claes Loefstroem

Margit Pelcman

Tom Fleck

Alexander Paptchikhine

Emma Andersson

Alf Nygren

Original Assignee

Biovitrum Ab Publ

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-19

Filing date

2003-06-18

Publication date

2008-10-06

2002-06-19 Priority claimed from SE0201881A external-priority patent/SE0201881D0/xx

2002-06-28 Priority claimed from SE0202041A external-priority patent/SE0202041D0/xx

2002-08-26 Priority claimed from SE0202516A external-priority patent/SE0202516D0/xx

2003-06-18 Application filed by Biovitrum Ab Publ filed Critical Biovitrum Ab Publ

2008-10-06 Application granted granted Critical

2008-10-06 Publication of DK1645558T3 publication Critical patent/DK1645558T3/da

Links

QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title abstract 4
229940076279 serotonin Drugs 0.000 title abstract 2
HCGFLVDMFDHYJD-UHFFFAOYSA-N 2-piperazin-1-ylpyrazine Chemical class C1CNCCN1C1=CN=CC=N1 HCGFLVDMFDHYJD-UHFFFAOYSA-N 0.000 title 1
102000006902 5-HT2C Serotonin Receptor Human genes 0.000 title 1
108010072553 5-HT2C Serotonin Receptor Proteins 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 3
210000003169 central nervous system Anatomy 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
Luminescent Compositions (AREA)
Pyridine Compounds (AREA)

DK05023471T 2002-06-19 2003-06-18 Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer DK1645558T3 (da)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
SE0201881A SE0201881D0 (sv)	2002-06-19	2002-06-19	Novel compounds, their use, and preparation
US39065602P	2002-06-21	2002-06-21
SE0202041A SE0202041D0 (sv)	2002-06-28	2002-06-28	Novel process
US40611902P	2002-08-26	2002-08-26
SE0202516A SE0202516D0 (sv)	2002-08-26	2002-08-26	Novel compounds, their use, and preparation
US41670102P	2002-10-07	2002-10-07
PCT/SE2003/001043 WO2004000829A1 (en)	2002-06-19	2003-06-18	Novel process

Publications (1)

Publication Number	Publication Date
DK1645558T3 true DK1645558T3 (da)	2008-10-06

Family

ID=30004077

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK03736405T DK1529043T3 (da)	2002-06-19	2003-06-18	Fremgangsmåde til fremstilling af 2-methylpiperazin-derivater
DK05023471T DK1645558T3 (da)	2002-06-19	2003-06-18	Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK03736405T DK1529043T3 (da)	2002-06-19	2003-06-18	Fremgangsmåde til fremstilling af 2-methylpiperazin-derivater

Country Status (16)

Country	Link
EP (2)	EP1529043B1 (da)
JP (4)	JP4592417B2 (da)
CN (1)	CN100334082C (da)
AT (2)	ATE398119T1 (da)
AU (1)	AU2003237746B8 (da)
CA (1)	CA2485532C (da)
CY (1)	CY1106225T1 (da)
DE (2)	DE60307286T2 (da)
DK (2)	DK1529043T3 (da)
ES (2)	ES2270051T3 (da)
HK (1)	HK1080079B (da)
NO (1)	NO20050279D0 (da)
NZ (1)	NZ536663A (da)
PT (2)	PT1645558E (da)
SI (2)	SI1645558T1 (da)
WO (1)	WO2004000829A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5173190B2 (ja)	2004-08-25	2013-03-27	武田薬品工業株式会社	腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
EP2727585A1 (en)	2006-05-16	2014-05-07	Takeda Pharmaceutical Company Limited	In-vivo screening method
AU2008312948C1 (en)	2007-10-16	2012-08-09	Daiichi Sankyo Company, Limited	Pyrimidyl indoline compound
EP2789338A3 (en)	2007-11-15	2015-01-14	Takeda Pharmaceutical Company Limited	Condensed pyridine derivate and use thereof
EA021079B1 (ru)	2009-06-15	2015-03-31	Такеда Фармасьютикал Компани Лимитед	Производные пиразинооксазепина
EP2510949A4 (en)	2009-12-11	2013-11-13	Astellas Pharma Inc	THERAPEUTICS FOR FIBROMYALGIA
GB201304811D0 (en) *	2013-03-15	2013-05-01	Proximagen Ltd	Novel treatment for hypertension
US20210052600A1 (en)	2017-12-27	2021-02-25	Takeda Pharmaceutical Company Limited	Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH06306075A (ja) *	1993-04-23	1994-11-01	Sanwa Kagaku Kenkyusho Co Ltd	エトキシベンズアミド誘導体
WO2000076984A2 (en) *	1999-05-21	2000-12-21	Biovitrum Ab	Novel compounds, their use and preparation
AR032318A1 (es) *	2000-04-13	2003-11-05	Pharmacia Corp	Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
NZ525699A (en) *	2000-11-20	2005-03-24	Biovitrum Ab	Piperazinylpyrazines compounds as antagonists of serotonin 5-HT2 receptor

2003
- 2003-06-18 SI SI200331283T patent/SI1645558T1/sl unknown
- 2003-06-18 ES ES03736405T patent/ES2270051T3/es not_active Expired - Lifetime
- 2003-06-18 AU AU2003237746A patent/AU2003237746B8/en not_active Ceased
- 2003-06-18 AT AT05023471T patent/ATE398119T1/de active
- 2003-06-18 DE DE60307286T patent/DE60307286T2/de not_active Expired - Lifetime
- 2003-06-18 PT PT05023471T patent/PT1645558E/pt unknown
- 2003-06-18 EP EP03736405A patent/EP1529043B1/en not_active Expired - Lifetime
- 2003-06-18 WO PCT/SE2003/001043 patent/WO2004000829A1/en not_active Ceased
- 2003-06-18 JP JP2004530934A patent/JP4592417B2/ja not_active Expired - Fee Related
- 2003-06-18 NZ NZ536663A patent/NZ536663A/en not_active IP Right Cessation
- 2003-06-18 CA CA2485532A patent/CA2485532C/en not_active Expired - Fee Related
- 2003-06-18 DE DE60321606T patent/DE60321606D1/de not_active Expired - Lifetime
- 2003-06-18 ES ES05023471T patent/ES2307102T3/es not_active Expired - Lifetime
- 2003-06-18 EP EP05023471A patent/EP1645558B1/en not_active Expired - Lifetime
- 2003-06-18 CN CNB038141612A patent/CN100334082C/zh not_active Expired - Fee Related
- 2003-06-18 DK DK03736405T patent/DK1529043T3/da active
- 2003-06-18 SI SI200330493T patent/SI1529043T1/sl unknown
- 2003-06-18 AT AT03736405T patent/ATE334980T1/de active
- 2003-06-18 HK HK06100135.0A patent/HK1080079B/zh not_active IP Right Cessation
- 2003-06-18 PT PT03736405T patent/PT1529043E/pt unknown
- 2003-06-18 DK DK05023471T patent/DK1645558T3/da active
2005
- 2005-01-18 NO NO20050279A patent/NO20050279D0/no not_active Application Discontinuation
2006
- 2006-10-30 CY CY20061101556T patent/CY1106225T1/el unknown
2010
- 2010-01-07 JP JP2010002229A patent/JP5378241B2/ja not_active Expired - Fee Related
2013
- 2013-02-04 JP JP2013019444A patent/JP2013116906A/ja active Pending
- 2013-07-08 JP JP2013142942A patent/JP2013227336A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
JP2013116906A (ja)	2013-06-13
AU2003237746A1 (en)	2004-01-06
DK1529043T3 (da)	2006-12-04
HK1080079A1 (zh)	2006-04-21
PT1645558E (pt)	2008-07-30
JP2010120949A (ja)	2010-06-03
JP2005537316A (ja)	2005-12-08
ATE398119T1 (de)	2008-07-15
EP1645558A1 (en)	2006-04-12
NO20050279D0 (no)	2005-01-18
CN100334082C (zh)	2007-08-29
SI1645558T1 (sl)	2008-10-31
CA2485532C (en)	2012-03-06
DE60321606D1 (de)	2008-07-24
ES2307102T3 (es)	2008-11-16
EP1529043B1 (en)	2006-08-02
HK1080079B (zh)	2008-03-14
WO2004000829A1 (en)	2003-12-31
AU2003237746B8 (en)	2010-01-28
CA2485532A1 (en)	2003-12-31
JP4592417B2 (ja)	2010-12-01
EP1645558B1 (en)	2008-06-11
SI1529043T1 (sl)	2006-12-31
PT1529043E (pt)	2006-12-29
AU2003237746B2 (en)	2009-12-17
CN1662523A (zh)	2005-08-31
DE60307286T2 (de)	2007-10-25
DE60307286D1 (de)	2006-09-14
ES2270051T3 (es)	2007-04-01
CY1106225T1 (el)	2011-06-08
EP1529043A1 (en)	2005-05-11
JP2013227336A (ja)	2013-11-07
ATE334980T1 (de)	2006-08-15
NZ536663A (en)	2007-05-31
JP5378241B2 (ja)	2013-12-25

Similar Documents

Publication	Publication Date	Title
BR0311494A (pt)	2005-03-29	Novos indóis substituìdos
SE0303180D0 (sv)	2003-11-26	Novel compounds
SE0302232D0 (sv)	2003-08-18	Novel Compounds
SE0203713D0 (sv)	2002-12-13	Novel compounds
DK1694318T3 (da)	2007-06-25	(S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
BRPI0410711A (pt)	2006-06-13	novos compostos
DK1379246T3 (da)	2009-01-26	Nocieptin-analoger
PA8493701A1 (es)	2002-07-30	Compuestos para tratar la obesidad
EA200970326A1 (ru)	2009-12-30	Алкильные производные в качестве метаботропных рецепторов глутамата
EA200601798A1 (ru)	2007-04-27	Замещенные соединения морфолина для лечения расстройств центральной нервной системы
EA201070143A1 (ru)	2010-08-30	Новые гетероароматические производные и их использование в качестве положительных аллостерических модуляторов метаботропных глутаматных рецепторов
EA200601194A1 (ru)	2006-10-27	Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
ECSP034811A (es)	2003-12-01	Derivados heterocicliloxi-, -tioxi - y - aminobenzazole tales como ligandos 5-hidroxitriptamina-6
NO20063275L (no)	2006-07-14	Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
DK1461318T3 (da)	2006-01-09	Tetrahydroquinolinanaloge som muscariniske agonister
EA200700909A1 (ru)	2007-12-28	Азаиндолкарбоксамиды
BR0316723A (pt)	2005-10-18	Derivados de anilinopirazol úteis para o tratamento de diabetes
SE0401465D0 (sv)	2004-06-08	New substituted piperdines as modulators of dopamine neurotransmission
EA200601895A1 (ru)	2007-04-27	3-(4-гетероарилциклогексиламино)циклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
MX2007002393A (es)	2007-08-14	Compuestos indolicos sustituidos y su uso como moduladores del receptor de 5-hidroxitriptamina 6 (5-ht6).
SE0502254L (sv)	2007-04-14	Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
DK1645558T3 (da)	2008-10-06	Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer
DK1301475T3 (da)	2007-04-02	Arylsulfonamider, som serotoninantagonist til behandling af obesitet
ATE499099T1 (de)	2011-03-15	Substituierte tetrahydro- chinolinsulfonamidverbindungen, ihre herstellung und ihre verwendung als medikamente
EA200602081A1 (ru)	2007-04-27	Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7